Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 193095, 16 pages
http://dx.doi.org/10.1155/2014/193095
Review Article

Nitric Oxide, Oxidative Stress, and Interplay in Diabetic Endothelial Dysfunction

1Vascular Pathology Laboratory, Istituto Dermopatico dell’Immacolata-IRCCS, 00167 Rome, Italy
2Molecular Cardiology Laboratory, Policlinico San Donato-IRCCS, San Donato Milanese, 20097 Milan, Italy
3Division of Cardiovascular Epigenetics, Department of Cardiology, Internal Medicine Clinic III, Goethe University, 60590 Frankfurt am Main, Germany

Received 18 November 2013; Accepted 12 January 2014; Published 5 March 2014

Academic Editor: Silvia M. Arribas

Copyright © 2014 Alessandra Magenta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Deanfield, J. P. Halcox, and T. J. Rabelink, “Endothelial function and dysfunction: testing and clinical relevance,” Circulation, vol. 115, no. 10, pp. 1285–1295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Napoli and L. J. Ignarro, “Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases,” Archives of Pharmacal Research, vol. 32, no. 8, pp. 1103–1108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Magenta, S. Greco, C. Gaetano et al., “Oxidative stress and microRNAs in vascular diseases,” International Journal of Molecular Sciences, vol. 14, no. 9, pp. 17319–17346, 2013. View at Google Scholar
  4. D. D. Gutterman, H. Miura, and Y. Liu, “Redox modulation of vascular tone: focus of potassium channel mechanisms of dilation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 4, pp. 671–678, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Miki and Y. Funato, “Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species,” Journal of Biochemistry, vol. 151, no. 3, pp. 255–261, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Yang, A. Huang, G. Kaley, and D. Sun, “eNOS uncoupling and endothelial dysfunction in aged vessels,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 297, no. 5, pp. H1829–H1836, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Higashi, K. Noma, M. Yoshizumi, and Y. Kihara, “Endothelial function and oxidative stress in cardiovascular diseases,” Circulation Journal, vol. 73, no. 3, pp. 411–418, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. P. D. Ray, B. Huang, and Y. Tsuji, “Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling,” Cellular Signalling, vol. 24, no. 5, pp. 981–990, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. E. Cooper and A. El-Osta, “Epigenetics: mechanisms and implications for diabetic complications,” Circulation Research, vol. 107, no. 12, pp. 1403–1413, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Giorgio, M. Trinei, E. Migliaccio, and P. G. Pelicci, “Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?” Nature Reviews Molecular Cell Biology, vol. 8, no. 9, pp. 722–728, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. D. P. Bartel, “MicroRNAs: target recognition and regulatory functions,” Cell, vol. 136, no. 2, pp. 215–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Huntzinger and E. Izaurralde, “Gene silencing by microRNAs: contributions of translational repression and mRNA decay,” Nature Reviews Genetics, vol. 12, no. 2, pp. 99–110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Guay, E. Roggli, V. Nesca, C. Jacovetti, and R. Regazzi, “Diabetes mellitus, a microRNA-related disease?” Translational Research, vol. 157, no. 4, pp. 253–264, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. K. Pandey, P. Agarwal, K. Kaur, and M. Datta, “MicroRNAs in diabetes: tiny players in big disease,” Cellular Physiology and Biochemistry, vol. 23, no. 4–6, pp. 221–232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. van de Bunt, K. J. Gaulton, L. Parts et al., “The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis,” PLoS ONE, vol. 8, no. 1, Article ID e55272, 2013. View at Google Scholar
  16. R. Muniyappa and M. J. Quon, “Insulin action and insulin resistance in vascular endothelium,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 10, no. 4, pp. 523–530, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Ware, D. D. Heistad, J. Flier, E. Salzman, and P. Weller, “Platelet-endothelium interactions,” The New England Journal of Medicine, vol. 328, no. 9, pp. 628–635, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. M. A. Vincent, M. Montagnani, and M. J. Quon, “Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium,” Current Diabetes Reports, vol. 3, no. 4, pp. 279–288, 2003. View at Google Scholar · View at Scopus
  19. M. Federici, A. Pandolfi, E. A. de Filippis et al., “G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells,” Circulation, vol. 109, no. 3, pp. 399–405, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. E. R. Duncan, P. A. Crossey, S. Walker et al., “Effect of endothelium-specific insulin resistance on endothelial function in vivo,” Diabetes, vol. 57, no. 12, pp. 3307–3314, 2008. View at Google Scholar
  21. Z. Y. Jiang, Y. Lin, A. Clemont et al., “Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats,” The Journal of Clinical Investigation, vol. 104, no. 4, pp. 447–457, 1999. View at Google Scholar · View at Scopus
  22. C. Nacci, M. Tarquinio, and M. Montagnani, “Molecular and clinical aspects of endothelial dysfunction in diabetes,” Internal and Emergency Medicine, vol. 4, no. 2, pp. 107–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. B. Wheatcroft, I. L. Williams, A. M. Shah, and M. T. Kearney, “Pathophysiological implications of insulin resistance on vascular endothelial function,” Diabetic Medicine, vol. 20, no. 4, pp. 255–268, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Montagnani, I. Golovchenko, I. Kim et al., “Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells,” The Journal of Biological Chemistry, vol. 277, no. 3, pp. 1794–1799, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Stocker and J. F. Keaney Jr., “Role of oxidative modifications in atherosclerosis,” Physiological Reviews, vol. 84, no. 4, pp. 1381–1478, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. A. San Martín, P. Du, A. Dikalova et al., “Reactive oxygen species-selective regulation of aortic inflammatory gene expression in type 2 diabetes,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 292, no. 5, pp. H2073–H2082, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Gao and G. E. Mann, “Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling,” Cardiovascular Research, vol. 82, no. 1, pp. 9–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. C. E. Tabit, W. B. Chung, N. M. Hamburg, and J. A. Vita, “Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications,” Reviews in Endocrine and Metabolic Disorders, vol. 11, no. 1, pp. 61–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Rajagopalan and D. G. Harrison, “Reversing endothelial dysfunction with ACE inhibitors: a new TREND?” Circulation, vol. 94, no. 3, pp. 240–243, 1996. View at Google Scholar · View at Scopus
  30. E. J. Henriksen, “Improvement of insulin sensitivity by antagonism of the renin-angiotensin system,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 293, no. 3, pp. R974–R980, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Oak and H. Cai, “Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice,” Diabetes, vol. 56, no. 1, pp. 118–126, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. G. M. Pieper, “Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin,” Journal of Cardiovascular Pharmacology, vol. 29, no. 1, pp. 8–15, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. N. J. Alp, S. Mussa, J. Khoo et al., “Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression,” The Journal of Clinical Investigation, vol. 112, no. 5, pp. 725–735, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Tousoulis, N. Papageorgiou, E. Androulakis, K. Paroutoglou, and C. Stefanadis, “Novel therapeutic strategies targeting vascular endothelium in essential hypertension,” Expert Opinion on Investigational Drugs, vol. 19, no. 11, pp. 1395–1412, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. R. Thomas, K. Chen, and J. F. Keaney Jr., “Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway,” The Journal of Biological Chemistry, vol. 277, no. 8, pp. 6017–6024, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. G. R. Drummond, H. Cai, M. E. Davis, S. Ramasamy, and D. G. Harrison, “Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide,” Circulation Research, vol. 86, no. 3, pp. 347–354, 2000. View at Google Scholar · View at Scopus
  37. C. Chen, L. J. Druhan, S. Varadharaj, Y. Chen, and J. L. Zweier, “Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme,” The Journal of Biological Chemistry, vol. 283, no. 40, pp. 27038–27047, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Giacco and M. Brownlee, “Oxidative stress and diabetic complications,” Circulation Research, vol. 107, no. 9, pp. 1058–1070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. C. D. Gonzalez, M. Lee, P. Marchetti et al., “The emerging role of autophagy in the pathophysiology of diabetes mellitus,” Autophagy, vol. 7, no. 1, pp. 2–11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Houstis, E. D. Rosen, and E. S. Lander, “Reactive oxygen species have a causal role in multiple forms of insulin resistance,” Nature, vol. 440, no. 7086, pp. 944–948, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Li, T. Ichikawa, J. S. Janicki, and T. Cui, “Targeting the Nrf2 pathway against cardiovascular disease,” Expert Opinion on Therapeutic Targets, vol. 13, no. 7, pp. 785–794, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. X. Cheng, R. C. M. Siow, and G. E. Mann, “Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway,” Antioxidants and Redox Signaling, vol. 14, no. 3, pp. 469–487, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Tan, T. Ichikawa, J. Li et al., “Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo,” Diabetes, vol. 60, no. 2, pp. 625–633, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Zhang, J. M. Patel, Y. D. Li, and E. R. Block, “Proinflammatory cytokines downregulate gene expression and activity of constitutive nitric oxide synthase in porcine pulmonary artery endothelial cells,” Research Communications in Molecular Pathology and Pharmacology, vol. 96, no. 1, pp. 71–87, 1997. View at Google Scholar · View at Scopus
  45. P. Libby, P. M. Ridker, and A. Maseri, “Inflammation and atherosclerosis,” Circulation, vol. 105, no. 9, pp. 1135–1143, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. J. A. Beckman, F. Paneni, F. Cosentino et al., “Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II,” European Heart Journal, vol. 34, no. 31, pp. 2444–2452, 2013. View at Google Scholar
  47. J. F. Keaney Jr., J. M. Massaro, M. G. Larson et al., “Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring study,” Journal of the American College of Cardiology, vol. 44, no. 1, pp. 168–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Festa, R. D'Agostino Jr., G. Howard, L. Mykkänen, R. P. Tracy, and S. M. Haffner, “Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS),” Circulation, vol. 102, no. 1, pp. 42–47, 2000. View at Google Scholar · View at Scopus
  49. A. D. Pradhan, J. E. Manson, N. Rifai, J. E. Buring, and P. M. Ridker, “C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus,” Journal of the American Medical Association, vol. 286, no. 3, pp. 327–334, 2001. View at Google Scholar · View at Scopus
  50. M. B. Schulze, E. B. Rimm, T. Li, N. Rifai, M. J. Stampfer, and F. B. Hu, “C-reactive protein and incident cardiovascular events among men with diabetes,” Diabetes Care, vol. 27, no. 4, pp. 889–894, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. B. B. Duncan, M. I. Schmidt, J. S. Pankow et al., “Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study,” Diabetes, vol. 52, no. 7, pp. 1799–1805, 2003. View at Google Scholar · View at Scopus
  52. M. A. Read, M. Z. Whitley, A. J. Williams, and T. Collins, “NF-κB and IκBα: an inducible regulatory system in endothelial activation,” Journal of Experimental Medicine, vol. 179, no. 2, pp. 503–512, 1994. View at Google Scholar · View at Scopus
  53. C. de Alvaro, T. Teruel, R. Hernandez, and M. Lorenzo, “Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner,” The Journal of Biological Chemistry, vol. 279, no. 17, pp. 17070–17078, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Kim, M. Pham, E. Maloney et al., “Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 11, pp. 1982–1988, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Bonfini, E. Migliaccio, G. Pelicci, L. Lanfrancone, and P. G. Pelicci, “Not all Shc's roads lead to Ras,” Trends in Biochemical Sciences, vol. 21, no. 7, pp. 257–261, 1996. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Pelicci, L. Dente, A. de Giuseppe et al., “A family of Shc related proteins with conserved PTB, CH1 and SH2 regions,” Oncogene, vol. 13, no. 3, pp. 633–641, 1996. View at Google Scholar · View at Scopus
  57. R. Sakai, J. T. Henderson, J. P. O'Bryan, A. J. Elia, T. M. Saxton, and T. Pawson, “The mammalian ShcB and ShcC phosphotyrosine docking proteins function in the maturation of sensory and sympathetic neurons,” Neuron, vol. 28, no. 3, pp. 819–833, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Migliaccio, S. Mele, A. E. Salcini et al., “Opposite effects of the p52(shc)/p46(shc) and p66(shc) splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway,” The EMBO Journal, vol. 16, no. 4, pp. 706–716, 1997. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Pelicci, L. Lanfrancone, F. Grignani et al., “A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction,” Cell, vol. 70, no. 1, pp. 93–104, 1992. View at Publisher · View at Google Scholar · View at Scopus
  60. M. K. Wills and N. Jones, “Teaching an old dogma new tricks: twenty years of Shc adaptor signalling,” Biochemical Journal, vol. 447, no. 1, pp. 1–16, 2012. View at Google Scholar
  61. E. Migliaccio, M. Giogio, S. Mele et al., “The p66(shc) adaptor protein controls oxidative stress response and life span in mammals,” Nature, vol. 402, no. 6759, pp. 309–313, 1999. View at Publisher · View at Google Scholar · View at Scopus
  62. E. Y. Skolnik, A. Batzer, N. Li et al., “The function of GRB2 in linking the insulin receptor to Ras signaling pathways,” Science, vol. 260, no. 5116, pp. 1953–1955, 1993. View at Google Scholar · View at Scopus
  63. A. Aronheim, D. Engelberg, N. Li, N. Ai-Alawi, J. Schlessinger, and M. Karin, “Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway,” Cell, vol. 78, no. 6, pp. 949–961, 1994. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Ohmichi, K. Matuoka, T. Takenawa, and A. R. Saltiel, “Growth factors differentially stimulate the phosphorylation of Shc proteins and their association with Grb2 in PC-12 pheochromocytoma cells,” The Journal of Biological Chemistry, vol. 269, no. 2, pp. 1143–1148, 1994. View at Google Scholar · View at Scopus
  65. M. Y. M. El-Shemerly, D. Besser, M. Nagasawa, and Y. Nagamine, “12-O-tetradecanoylphorbol-13-acetate activates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of SOS involving serine phosphorylation of Shc in NIH3T3 cells,” The Journal of Biological Chemistry, vol. 272, no. 49, pp. 30599–30602, 1997. View at Publisher · View at Google Scholar · View at Scopus
  66. A. W. Kao, S. B. Waters, S. Okada, and J. E. Pessin, “Insulin stimulates the phosphorylation of the 66- and 52-kilodalton Shc isoforms by distinct pathways,” Endocrinology, vol. 138, no. 6, pp. 2474–2480, 1997. View at Publisher · View at Google Scholar · View at Scopus
  67. C. P. Yang and S. B. Horwitz, “Taxol mediates serine phosphorylation of the 66-kDa Shc isoform,” Cancer Research, vol. 60, no. 18, pp. 5171–5178, 2000. View at Google Scholar · View at Scopus
  68. S. Nemoto and T. Finkel, “Redox regulation of forkhead proteins through a p66Shc-dependent signaling pathway,” Science, vol. 295, no. 5564, pp. 2450–2452, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. F. A. Khanday, T. Yamamori, I. Mattagajasingh et al., “Rac1 leads to phosphorylation-dependent increase in stability of the p66Shc adaptor protein: role in Rac1-induced oxidative stress,” Molecular Biology of the Cell, vol. 17, no. 1, pp. 122–129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. P. Pinton, A. Rimessi, S. Marchi et al., “Protein kinase C β and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc,” Science, vol. 315, no. 5812, pp. 659–663, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Giorgio, E. Migliaccio, F. Orsini et al., “Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis,” Cell, vol. 122, no. 2, pp. 221–233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. P. Pinton and R. Rizzuto, “P66Shc, oxidative stress and aging: importing a lifespan determinant into mitochondria,” Cell Cycle, vol. 7, no. 3, pp. 304–308, 2008. View at Google Scholar · View at Scopus
  73. A. Rimessi, R. Rizzuto, and P. Pinton, “Differential recruitment of PKC isoforms in HeLa cells during redox stress,” Cell Stress and Chaperones, vol. 12, no. 4, pp. 291–298, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Li, K. Chiou, and D. A. Kass, “Shear stress inhibition of H2O2 induced p66Shc phosphorylation by ASK1-JNK inactivation in endothelium,” Heart and Vessels, vol. 22, no. 6, pp. 423–427, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. Y. M. Yannoni, M. Gaestel, and L. Lin, “P66ShcA interacts with MAPKAP kinase 2 and regulates its activity,” FEBS Letters, vol. 564, no. 1-2, pp. 205–211, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. P. Francia, C. delli Gatti, M. Bachschmid et al., “Deletion of p66Shc gene protects against age-related endothelial dysfunction,” Circulation, vol. 110, no. 18, pp. 2889–2895, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Trinei, M. Giorgio, A. Cicalese et al., “A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis,” Oncogene, vol. 21, no. 24, pp. 3872–3878, 2002. View at Publisher · View at Google Scholar · View at Scopus
  78. C. Napoli, I. Martin-Padura, F. de Nigris et al., “Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 4, pp. 2112–2116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. G. Graiani, C. Lagrasta, E. Migliaccio et al., “Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage,” Hypertension, vol. 46, no. 2, pp. 433–440, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. O. R. Koch, S. Fusco, S. C. Ranieri et al., “Role of the life span determinant p66ShcA in ethanol-induced liver damage,” Laboratory Investigation, vol. 88, no. 7, pp. 750–760, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. G. Zaccagnini, F. Martelli, P. Fasanaro et al., “P66ShcA modulates tissue response to hindlimb ischemia,” Circulation, vol. 109, no. 23, pp. 2917–2923, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. G. Zaccagnini, F. Martelli, A. Magenta et al., “P66ShcA and oxidative stress modulate myogenic differentiation and skeletal muscle regeneration after hind limb ischemia,” The Journal of Biological Chemistry, vol. 282, no. 43, pp. 31453–31459, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. F. C. Franzeck, D. Hof, R. D. Spescha et al., “Expression of the aging gene p66Shc is increased in peripheral blood monocytes of patients with acute coronary syndrome but not with stable coronary artery disease,” Atherosclerosis, vol. 220, no. 1, pp. 282–286, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. G. G. Camici, M. Schiavoni, P. Francia et al., “Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 12, pp. 5217–5222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. G. H. Kim, J. J. Ryan, and S. L. Archer, “The role of redox signaling in epigenetics and cardiovascular disease,” Antioxidants and Redox Signaling, vol. 18, no. 15, pp. 1920–1936, 2013. View at Google Scholar
  86. A. Malhotra, H. Vashistha, V. S. Yadav et al., “Inhibition of p66ShcA redox activity in cardiac muscle cells attenuates hyperglycemia-induced oxidative stress and apoptosis,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 296, no. 2, pp. H380–H388, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. N. Ahmed, “Advanced glycation endproducts: role in pathology of diabetic complications,” Diabetes Research and Clinical Practice, vol. 67, no. 1, pp. 3–21, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. E. Schleicher and U. Friess, “Oxidative stress, AGE, and atherosclerosis,” Kidney International, vol. 72, no. 106, pp. S17–S26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. W. Cai, J. C. He, L. Zhu, X. Chen, G. E. Striker, and H. Vlassara, “AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66Shc-dependent FKHRL1 phosphorylation,” American Journal of Physiology—Cell Physiology, vol. 294, no. 1, pp. C145–C152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. J. Chintapalli, S. Yang, D. Opawumi et al., “Inhibition of wild-type p66ShcA in mesangial cells prevents glycooxidant-dependent FOXO3a regulation and promotes the survival phenotype,” American Journal of Physiology—Renal Physiology, vol. 292, no. 2, pp. F523–F530, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. E. W.-F. Lam, R. E. Francis, and M. Petkovic, “FOXO transcription factors: key regulators of cell fate,” Biochemical Society Transactions, vol. 34, no. 5, pp. 722–726, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Purdom and Q. M. Chen, “Linking oxidative stress and genetics of aging with p66Shc signaling and forkhead transcription factors,” Biogerontology, vol. 4, no. 4, pp. 181–191, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. G. Pani, O. R. Koch, and T. Galeotti, “The p53-p66Shc-Manganese Superoxide Dismutase (MnSOD) network: a mitochondrial intrigue to generate reactive oxygen species,” International Journal of Biochemistry and Cell Biology, vol. 41, no. 5, pp. 1002–1005, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. T. Yamamori, A. R. White, I. Mattagajasingh et al., “P66Shc regulates endothelial NO production and endothelium-dependent vasorelaxation: implications for age-associated vascular dysfunction,” Journal of Molecular and Cellular Cardiology, vol. 39, no. 6, pp. 992–995, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Menini, C. Iacobini, C. Ricci et al., “Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation,” Diabetologia, vol. 50, no. 9, pp. 1997–2007, 2007. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Natalicchio, L. Laviola, C. de Tullio et al., “Role of the p66Shc isoform in insulin-like growth factor I receptor signaling through MEK/Erk and regulation of actin cytoskeleton in rat myoblasts,” The Journal of Biological Chemistry, vol. 279, no. 42, pp. 43900–43909, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. A. Natalicchio, F. de Stefano, S. Perrini et al., “Involvement of the p66Shc protein in glucose transport regulation in skeletal muscle myoblasts,” American Journal of Physiology—Endocrinology and Metabolism, vol. 296, no. 2, pp. E228–E237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. E. Pagnin, G. Fadini, R. de Toni, A. Tiengo, L. Calò, and A. Avogaro, “Diabetes induces p66Shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 2, pp. 1130–1136, 2005. View at Publisher · View at Google Scholar · View at Scopus
  99. T. Thum, D. Fraccarollo, M. Schultheiss et al., “Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes,” Diabetes, vol. 56, no. 3, pp. 666–674, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. V. Di Stefano, C. Cencioni, G. Zaccagnini, A. Magenta, M. C. Capogrossi, and F. Martelli, “P66ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose,” Cardiovascular Research, vol. 82, no. 3, pp. 421–429, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. C. Napoli, J. L. Witztum, F. Calara, F. de Nigris, and W. Palinski, “Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses,” Circulation Research, vol. 87, no. 10, pp. 946–952, 2000. View at Google Scholar · View at Scopus
  102. C. Napoli, F. de Nigris, and W. Palinski, “Multiple role of reactive oxygen species in the arterial wall,” Journal of Cellular Biochemistry, vol. 82, no. 4, pp. 674–682, 2001. View at Publisher · View at Google Scholar · View at Scopus
  103. C. Napoli, F. de Nigris, J. S. Welch et al., “Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray,” Circulation, vol. 105, no. 11, pp. 1360–1367, 2002. View at Publisher · View at Google Scholar · View at Scopus
  104. A. Boullier, D. A. Bird, M. Chang et al., “Scavenger receptors, oxidized LDL, and atherosclerosis,” Annals of the New York Academy of Sciences, vol. 947, pp. 214–223, 2001. View at Google Scholar · View at Scopus
  105. A. Bosutti, G. Grassi, M. Zanetti et al., “Relation between the plasma levels of LDL-cholesterol and the expression of the early marker of inflammation long pentraxin PTX3 and the stress response gene p66(ShcA) in pacemaker-implanted patients,” Clinical and Experimental Medicine, vol. 7, no. 1, pp. 16–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  106. T. Minamino, H. Miyauchi, T. Yoshida, Y. Ishida, H. Yoshida, and I. Komuro, “Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction,” Circulation, vol. 105, no. 13, pp. 1541–1544, 2002. View at Publisher · View at Google Scholar · View at Scopus
  107. S. V. Brodsky, O. Gealekman, J. Chen et al., “Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen,” Circulation Research, vol. 94, no. 3, pp. 377–384, 2004. View at Publisher · View at Google Scholar · View at Scopus
  108. H. Matsui-Hirai, T. Hayashi, S. Yamamoto et al., “Dose-dependent modulatory effects of insulin on glucose-induced endothelial senescence in vitro and in vivo: a relationship between telomeres and nitric oxide,” Journal of Pharmacology and Experimental Therapeutics, vol. 337, no. 3, pp. 591–599, 2011. View at Publisher · View at Google Scholar · View at Scopus
  109. R. J. Colman, R. M. Anderson, S. C. Johnson et al., “Caloric restriction delays disease onset and mortality in rhesus monkeys,” Science, vol. 325, no. 5937, pp. 201–204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. B. Rogina and S. L. Helfand, “Sir2 mediates longevity in the fly through a pathway related to calorie restriction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 45, pp. 15998–16003, 2004. View at Publisher · View at Google Scholar · View at Scopus
  111. M. Potente and S. Dimmeler, “Emerging roles of SIRT1 in vascular endothelial homeostasis,” Cell Cycle, vol. 7, no. 14, pp. 2117–2122, 2008. View at Google Scholar · View at Scopus
  112. S. Zhou, H. Chen, Y. Wan et al., “Repression of p66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction,” Circulation Research, vol. 109, no. 6, pp. 639–648, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. R. R. Alcendor, S. Gao, P. Zhai et al., “Sirt1 regulates aging and resistance to oxidative stress in the heart,” Circulation Research, vol. 100, no. 10, pp. 1512–1521, 2007. View at Publisher · View at Google Scholar · View at Scopus
  114. I. Mattagajasingh, C. Kim, A. Naqvi et al., “SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 37, pp. 14855–14860, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. A. Brunet, L. B. Sweeney, J. F. Sturgill et al., “Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase,” Science, vol. 303, no. 5666, pp. 2011–2015, 2004. View at Publisher · View at Google Scholar · View at Scopus
  116. J. Luo, A. Y. Nikolaev, S. Imai et al., “Negative control of p53 by Sir2α promotes cell survival under stress,” Cell, vol. 107, no. 2, pp. 137–148, 2001. View at Publisher · View at Google Scholar · View at Scopus
  117. H. Chen, Y. Wan, S. Zhou et al., “Endothelium-specific SIRT1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence,” Science China Life Sciences, vol. 55, no. 6, pp. 467–473, 2012. View at Google Scholar
  118. M. A. Reddy, W. Jin, L. Villeneuve et al., “Pro-inflammatory role of MicroRNA-200 in vascular smooth muscle cells from diabetic mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 3, pp. 721–729, 2012. View at Publisher · View at Google Scholar · View at Scopus
  119. S. Brabletz and T. Brabletz, “The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer?” EMBO Reports, vol. 11, no. 9, pp. 670–677, 2010. View at Publisher · View at Google Scholar · View at Scopus
  120. A. Magenta, C. Cencioni, P. Fasanaro et al., “MiR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition,” Cell Death and Differentiation, vol. 18, no. 10, pp. 1628–1639, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. J. Rosati, F. Spallotta, S. Nanni et al., “Smad-interacting protein-1 and microRNA 200 family define a nitric oxide-dependent molecular circuitry involved in embryonic stem cell mesendoderm differentiation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 4, pp. 898–907, 2011. View at Publisher · View at Google Scholar · View at Scopus
  122. L. M. Villeneuve, M. Kato, M. A. Reddy, M. Wang, L. Lanting, and R. Natarajan, “Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1,” Diabetes, vol. 59, no. 11, pp. 2904–2915, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. S. Manca, A. Magrelli, S. Cialfi et al., “Oxidative stress activation of miR-125b is part of the molecular switch for Hailey-Hailey disease manifestation,” Experimental Dermatology, vol. 20, no. 11, pp. 932–937, 2011. View at Publisher · View at Google Scholar · View at Scopus
  124. J. M. Wang, J. Tao, D. D. Chen et al., “MicroRNA miR-27b rescues bone Marrow-Derived angiogenic cell function and accelerates wound healing in type 2 diabetes mellitus,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 1, pp. 99–109, 2014. View at Google Scholar
  125. P. Fasanaro, Y. D'Alessandra, V. Di Stefano et al., “MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3,” The Journal of Biological Chemistry, vol. 283, no. 23, pp. 15878–15883, 2008. View at Publisher · View at Google Scholar · View at Scopus
  126. G. Zaccagnini, B. Maimone, V. Di Stefano et al., “Hypoxia-induced miR-210 modulates tissue response to acute peripheral ischemia,” Antioxid Redox Signal, 2013. View at Publisher · View at Google Scholar
  127. S. Greco, P. Fasanaro, S. Castelvecchio et al., “MicroRNA dysregulation in diabetic ischemic heart failure patients,” Diabetes, vol. 61, no. 6, pp. 1633–1641, 2012. View at Google Scholar
  128. Y. Li, M. A. Reddy, F. Miao et al., “Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-κB-dependent inflammatory genes: relevance to diabetes and inflammation,” The Journal of Biological Chemistry, vol. 283, no. 39, pp. 26771–26781, 2008. View at Publisher · View at Google Scholar · View at Scopus
  129. A. El-Osta, D. Brasacchio, D. Yao et al., “Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia,” Journal of Experimental Medicine, vol. 205, no. 10, pp. 2409–2417, 2008. View at Google Scholar
  130. R. Candido, K. A. Jandeleit-Dahm, Z. Cao et al., “Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice,” Circulation, vol. 106, no. 2, pp. 246–253, 2002. View at Publisher · View at Google Scholar · View at Scopus
  131. R. Candido, T. J. Allen, M. Lassila et al., “Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis,” Circulation, vol. 109, no. 12, pp. 1536–1542, 2004. View at Publisher · View at Google Scholar · View at Scopus
  132. D. S. Kerr, “Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade,” Molecular Genetics and Metabolism, vol. 99, no. 3, pp. 246–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  133. F. Paneni, P. Mocharla, A. Akhmedov et al., “Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes,” Circulation Research, vol. 111, no. 3, pp. 278–289, 2012. View at Google Scholar
  134. Y. R. Kim, C. S. Kim, A. Naqvi et al., “Epigenetic upregulation of p66Shc mediates low-density lipoprotein cholesterol-induced endothelial cell dysfunction,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 303, no. 2, pp. H189–H196, 2012. View at Google Scholar
  135. T. Münzel, T. Gori, R. M. Bruno, and S. Taddei, “Is oxidative stress a therapeutic target in cardiovascular disease?” European Heart Journal, vol. 31, no. 22, pp. 2741–2748, 2010. View at Google Scholar · View at Scopus
  136. N. G. Stephens, A. Parsons, P. M. Schofield et al., “Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS),” The Lancet, vol. 347, no. 9004, pp. 781–786, 1996. View at Publisher · View at Google Scholar · View at Scopus
  137. R. M. Salonen, K. Nyyssönen, J. Kaikkonen et al., “Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the antioxidant supplementation in atherosclerosis prevention (ASAP) study,” Circulation, vol. 107, no. 7, pp. 947–953, 2003. View at Publisher · View at Google Scholar · View at Scopus
  138. P. M. Kris-Etherton, A. H. Lichtenstein, B. V. Howard, D. Steinberg, and J. L. Witztum, “Antioxidant vitamin supplements and cardiovascular disease,” Circulation, vol. 110, no. 5, pp. 637–641, 2004. View at Publisher · View at Google Scholar · View at Scopus
  139. H. D. Sesso, J. E. Buring, W. G. Christen et al., “Vitamins E and C in the prevention of cardiovascular disease in men: the physicians' health study II randomized controlled trial,” Journal of the American Medical Association, vol. 300, no. 18, pp. 2123–2133, 2008. View at Publisher · View at Google Scholar · View at Scopus
  140. G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti, and C. Gluud, “Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis,” Journal of the American Medical Association, vol. 297, no. 8, pp. 842–857, 2007. View at Publisher · View at Google Scholar · View at Scopus
  141. J. Stoclet, T. Chataigneau, M. Ndiaye et al., “Vascular protection by dietary polyphenols,” European Journal of Pharmacology, vol. 500, no. 1–3, pp. 299–313, 2004. View at Publisher · View at Google Scholar · View at Scopus
  142. L. Hooper, P. A. Kroon, E. B. Rimm et al., “Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials,” American Journal of Clinical Nutrition, vol. 88, no. 1, pp. 38–50, 2008. View at Google Scholar · View at Scopus
  143. T. Szkudelski, “Resveratrol-induced inhibition of insulin secretion from rat pancreatic islets: evidence for pivotal role of metabolic disturbances,” American Journal of Physiology—Endocrinology and Metabolism, vol. 293, no. 4, pp. E901–E907, 2007. View at Publisher · View at Google Scholar · View at Scopus
  144. T. Szkudelski and K. Szkudelska, “Anti-diabetic effects of resveratrol,” Annals of the New York Academy of Sciences, vol. 1215, no. 1, pp. 34–39, 2011. View at Publisher · View at Google Scholar · View at Scopus
  145. P. Palsamy and S. Subramanian, “Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic β-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats,” Journal of Cellular Physiology, vol. 224, no. 2, pp. 423–432, 2010. View at Publisher · View at Google Scholar · View at Scopus
  146. H. Ghanim, C. L. Sia, K. Korzeniewski et al., “A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 5, pp. 1409–1414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  147. M. Lagouge, C. Argmann, Z. Gerhart-Hines et al., “Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α,” Cell, vol. 127, no. 6, pp. 1109–1122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  148. S. Timmers, M. K. Hesselink, and P. Schrauwen, “Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?” Annals of the New York Academy of Sciences, vol. 1290, pp. 83–89, 2013. View at Google Scholar
  149. H. C. Williams and K. K. Griendling, “NADPH oxidase inhibitors: new antihypertensive agents?” Journal of Cardiovascular Pharmacology, vol. 50, no. 1, pp. 9–16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  150. R. Cangemi, L. Loffredo, R. Carnevale et al., “Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin E,” European Heart Journal, vol. 29, no. 1, pp. 54–62, 2008. View at Publisher · View at Google Scholar · View at Scopus
  151. S. John, C. Delles, J. Jacobi et al., “Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks,” Journal of the American College of Cardiology, vol. 37, no. 5, pp. 1351–1358, 2001. View at Google Scholar
  152. H. P. Friedl, D. J. Smith, G. O. Till, P. D. Thomson, D. S. Louis, and P. A. Ward, “Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity,” The American Journal of Pathology, vol. 136, no. 3, pp. 491–495, 1990. View at Google Scholar · View at Scopus
  153. R. Butler, A. D. Morris, J. J. F. Belch, A. Hill, and A. D. Struthers, “Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension,” Hypertension, vol. 35, no. 3, pp. 746–751, 2000. View at Google Scholar · View at Scopus
  154. T. Gori and J. D. Parker, “Nitrate-induced toxicity and preconditioning: a rationale for reconsidering the use of these drugs,” Journal of the American College of Cardiology, vol. 52, no. 4, pp. 251–254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  155. S. R. Steinhubl, “Why have antioxidants failed in clinical trials?” American Journal of Cardiology, vol. 101, no. 10, pp. 14D–19D, 2008. View at Publisher · View at Google Scholar · View at Scopus